Remixtherapeutics
Head of Medical Affairs
Watertown, MA . Posted a month ago
The role
The Head of Medical Affairs will provide medical affairs leadership for REM-422 and contribute to future programs. This person will define the medical affairs function, hire a team, and act as the external scientific voice for the company.
What you will do
- Lead development and execution of Medical Strategy for REM-422 in ACC.
- Build scientific awareness of ACC across medical oncology, head and neck, and ENT communities.
- Map the ACC patient journey.
- Advance understanding of MYB biomarker testing.
- Generate real world insight on current management patterns and unmet need.
- Engage leading ACC, head and neck, and hematology investigators and build the KOL network.
- Oversee advisory boards, congress strategy, and scientific exchange.
- Build partnerships with ACC advocacy organizations.
- Represent Remix externally in scientific and business development settings.
- Own publication strategy and execution across ACC and AML/HR-MDS.
Required qualifications
- Advanced life science degree required.
- 10+ years in medical affairs and prior leadership of the function.
- Oncology experience is required.
- Built a Medical Affairs function from an early state.
- Existing relationships across oncology academic institutions.
- Excellent written and verbal communication skills.
- Demonstrated ability to operate effectively in a highly collaborative, cross-functional, and fast-paced biotechnology environment.
Nice to have
- MD or equivalent medical degree preferred
- PhD or PharmD considered
- Solid tumors strongly preferred
- head and neck or salivary gland is a distinct advantage
- Launch experience preferred
- Global perspective preferred
Benefits
- bonus
- equity
- benefits
About the company
Remix Therapeutics uses a proprietary in-house technology platform to identify small molecules that influence the expression of disease-driving mRNAs and proteins. The company was recognized as one of BioSpace’s Best Places to Work in Boston 2025.